BioCryst Pharmaceuticals | BCRX - Ebitda





Ebitda Perubahan Tanggal
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Chugai Pharma JPY 193.44B 23.07B 2026-09
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
DBV Technologies USD -61.2M 15.3M 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Glaxosmithkline GBP 2.93B 154M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novavax USD 19.36M 190.79M 2025-12
PTC Therapeutics USD 161.9M 99.92M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06